Request to Join
has invited you to join this group
Martin Llewelyn is Professor of Infectious Diseases at Brighton and Sussex Medical School and a Consultant in Infectious Diseases at Brighton and Sussex University Hospitals. His clinical work and research are both focused on the common, life-threatening bacterial infections which affect patients in the NHS and in particular, healthcare associated and antibiotic resistant infections. Major current themes of his research are application of microbial genome sequencing to the study of transmission and pathogenesis of S. aureus infection and reducing antibiotic overuse in hospital through optimizing treatment strategies.
Marc Bonten earned his MD (1991) and PhD (“the role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia, 1994) at the Maastricht University Medical School, the Netherlands. He registered as internist in 2000, as infectious disease specialist in 2002 and as clinical microbiologist in 2008, all at the University Medical Center Utrecht, the Netherlands. Since August 2008 he is head of the Department of Medical Microbiology and leading the research group of infectious Disease Epidemiology of the Julius Center of Health Sciences and Primary Care, both at the UMC Utrecht, where he is professor of molecular epidemiology of infectious diseases since 2002. He has been a principal investigator in many large scale epidemiologic studies and investigator-initiated randomized trials of prevention and treatment of infectious diseases. His experience covers the full range of epidemiologic study designs including clinical trials, cohorts, case-control studies and mathematical modelling to study antibiotic resistance and infection prevention. Specific research interests include the epidemiology of antibiotic-resistant bacteria such as VRE, MRSA and MDR Enterobacteriaceae, selective decontamination in intensive care unit patients, prevention of ventilator-associated pneumonia, treatment of community-acquired pneumonia, and prevention and treatment of community-acquired pneumonia.
Vance Fowler, MD, MHS, Professor, Departments of Medicine and Molecular Genetics & Microbiology, Duke University Medical Center. Dr. Fowler has extensive expertise in clinical and translational research in bacterial infections. Dr. Fowler created the Staphylococcus aureus Bacteremia Group and co-founded the International Collaboration on Endocarditis. He is a project PI in the Clinical Trials Transformation Initiative (CTTI) and the Communicating PI of the Antibacterial Resistance Leadership Group.
Dilip qualified from Aberdeen University in 1984, and has subsequently training in internal medicine/infection/tropical medicine in Aberdeen, Glasgow and Birmingham, UK. Since 2014 he is the Co-Director of the Tayside Academic Health Sciences Partnership [AHSP], the first of its kind in Scotland and with the primary aim of enabling innovation in the health and social care sector. He also has been the recent Chairman of Scottish Government Funded Scottish Antimicrobial Prescribing Group (SAPG) from February 2008. SAPG is a national clinical antimicrobial stewardship programme. Chair of the European Study Group on Antibiotic Policies [ESGAP] from 2011–14 and President of the British Society for Antimicrobial Chemotherapy [BSAC]; National Specialty Adviser for Infectious Diseases to the Scottish Government Health Department; External advisor on Antimicrobial Stewardship Policy to a number of professional societies and non-UK governmental bodies; Programme director of the first Massive open on line course [MOOC] on Antimicrobial stewardship. In 2015 he was awarded the Order of the British Empire [OBE] by Her Majesty the Queen for outstanding services to the treatment of Infectious Diseases Dilip has authored more than 250 peer reviewed publications and has a range of local, national and international contributions to research, education, quality improvement, guidelines and policy, particularly in the field of antimicrobial stewardship, that aim to implement good practice and creating care that is based on high quality and cost–effectiveness.
Susan Hopkins is the Clinical Director of Infection at the Royal Free London NHS Foundation Trust and Lead Healthcare Epidemiologist for the Programme at Public Health England where she leads the English Surveillance Programme for Antimicrobial Use and Resistance and national acute hospital surveys of Healthcare-care associated infections and antimicrobial use.
Professor Moore is an academic General Practitioner. He has 30 years experience as a GP and still works part time in a Salisbury practice. His practice has been engaged in research since 1993 qualifying for government funding in 1995 and is now actively contributing to Wessex Clinical Research Network. He is Unit Head for the Primary Care and Population Sciences group in the Faculty of Medicine at the University of Southampton. The primary care group is a member of the NIHR School for Primary Care Research and aims to improve the management of disorders with major impact on public health. His research focuses on the optimal management of acute minor illness with an emphasis on antibiotic sparing strategies. He has promoted the antimicrobial stewardship agenda and is a member of APRHAI the government advisory board for antimicrobial resistance. He has also been interested in the primary care management of depression and the potential overuse of antidepressants.